Nan Hou

A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C

Ming‐Lung Yu, CY Dai, Jee‐Fu Huang et al. · Gut · 2006 · 285 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Sustained virological response to interferon reduces cirrhosis in chronic hepatitis C: a 1386‐patient study from Taiwan

Jee‐Fu Huang, Ming‐Lung Yu, C. Lee et al. · Alimentary Pharmacology & Therapeutics · 2007 · 64 citations · Full text

Medicine, Internal Medicine, Hepatic Pharmacotherapy +16

Bacterial infection and neutropenia during peginterferon plus ribavirin combination therapy in patients with chronic hepatitis C with and without baseline neutropenia in clinical practice

Jeng‐Fu Yang, M.-Y. Hsieh, Nan Hou et al. · Alimentary Pharmacology & Therapeutics · 2009 · 20 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

SOD3 suppresses early cellular immune responses to parasite infection

Qilong Li, Kunying Lv, Ning Jiang et al. · Nature Communications · 2024 · 18 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17